Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System™

 Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Glucose and
                        Beta-Ketone Monitoring System™

Only inpatient blood glucose monitoring system among leading hospital brands
to use individually foil-wrapped test strips, helping reduce risk of test
strip cross-contamination

PR Newswire

ABBOTT PARK, Ill., July 25, 2013

ABBOTT PARK, Ill., July 25, 2013 /PRNewswire/ -- Abbott (NYSE: ABT)today
announced that it has received U.S. Food and Drug Administration (FDA)
clearance for its FreeStyle Precision Pro Blood Glucose and Beta-Ketone
Monitoring System™, an advanced blood glucose monitoring system designed to
address the key needs of hospital customers: high accuracy, efficient
operation, dual-band wireless access to immediate test results, and helps in
the reduction of the risk of test strip cross-contamination.

"The FreeStyle Precision Pro system represents a significant step forward as
we work to provide tools to improve the way hospitals manage patients' glucose
levels," said Heather L. Mason, senior vice president, Diabetes Care, Abbott.
"It makes the data available in real time, thanks to the meter's new wireless
capabilities. With its individually foil-wrapped test strips, the system is
also designed to help reduce test strip cross-contamination in hospital
environments."

Key features of Abbott's FreeStyle Precision Pro system include:

Addresses Hospital Needs for Cross-Contamination Control

  oAbbott's FreeStyle Precision Pro system is the only inpatient blood
    glucose monitoring system among leading hospital brands to use
    individually foil-wrapped test strips,^i helping reduce the risk of test
    strip cross-contamination of blood and bacteria.^ii This Abbott exclusive
    advantage helps hospitals comply with the Centers for Disease Control and
    Prevention regarding protection of unused supplies.^iii
  oThe device conforms to FDA requirements for cleaning and disinfection,
    which require devices to be disinfected after each use. The FreeStyle
    Precision Pro Meter also offers a replaceable strip port that can be
    removed for replacement on-site.

Dual-Band Wireless Connectivity Enables Real-Time Access to Test Results and
Improves Staff Workflow

  oAbbott's FreeStyle Precision Pro system allows for real-time, dual-band
    wireless communication between the handheld meter at the patient bedside
    and the hospital information system, giving clinical staff immediate
    access to patient test results throughout their facility. The dual-band
    wireless technology enables the flexibility of wireless access within a
    hospital's Wi-Fi-enabled network when properly configured. The system is
    designed so that clinical operators need not interrupt their busy workflow
    to conduct routine docking or attach a data cable to download patient
    results, saving time while also providing access to real-time data. This
    helps ensure immediate access to test results through the hospital's
    electronic medical record system, and to facilitate clinical decision
    whenever it is needed.

Designed with Higher Performance Characteristics

  oThe FreeStyle Precision Pro system features a new algorithm to correct for
    hematocrit interference. The test process occurs in five seconds for
    prompt and accurate delivery of test results.

2D Barcode Technology for Patient Identification

  oThe new system adds technology to read newer 2D barcodes, which are
    becoming more prevalent in healthcare identification systems. This
    technology enhances the accuracy of patient identification with TrueID™
    technology.

About Abbott Diabetes Care

Abbott Diabetes Care, based in Alameda, Calif., is a leader in developing,
manufacturing and marketing glucose monitoring systems designed to help people
better manage their diabetes. Additional information about Abbott Diabetes
Care may be found at www.abbottdiabetescare.com.

About Abbott

Abbott is a global healthcare company devoted to improving life through the
development of products and technologies that span the breadth of healthcare.
With a portfolio of leading, science-based offerings in diagnostics, medical
devices, nutritionals and branded generic pharmaceuticals, Abbott serves
people in more than 150 countries and employs approximately 70,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

^i As of July 2013 among leading hospital brands of blood glucose test strips
in the U.S. (LifeScan, Roche, and Nova Biomedical)

^ii Data on file at Microbe Inotech Laboratories, Inc., St. Louis, MO., Report
MILB-8486A, March 2012

^iii Diabetes and Viral Hepatitis: Important Information on Glucose
Monitoring, Centers for Disease Control:
http://www.cdc.gov/hepatitis/Settings/GlucoseMonitoring.htm

SOURCE Abbott

Website: http://www.abbott.com
Contact: Media, Jonathon Hamilton, (408) 624-0314, or Jessica Sachariason,
(510) 239-2690; Financial, Tina Ventura, (847) 935-9390